Original Research Paper IJRRMS 203;3(3) Anemia and neuropathy in type- 2 diabetes mellitus: A case control study Sinha Babu A, Chakrabarti A, Karmakar RN ABSTRACT Background: Albuminuria and retinopathy, two microvascular complications of diabetes are known to be associated with anemia. Whether diabetic neuropathy, another complication of diabetes, is also associated with anemia is not known. Aim: To find out the association between anemia and diabetic neuropathy in type 2 diabetes mellitus. Methods: Fifty patients of type 2 diabetes mellitus with diabetic neuropathy as 'cases' and age sex matched fifty 'controls' were selected from patients attending the diabetic clinic of College of Medicine and JNM hospital. All the cases and controls were free from retinopathy and albuminuria and were investigated for anemia. Appropriate statistical analysis was done to find out any association between anemia and diabetic neuropathy. Results: Anemia was found to be 68% and 42% among cases and controls respectively and the difference was statistically significant. Both peripheral and autonomic neuropathies were present in 58% cases, only peripheral neuropathy in 30% and pure antonomic neuropathy in 2% cases. No significant association of anemia with any particular type of neuropathy was evident. Conclusion: Addressing anemia in diabetic individuals may have potential to make a great impact in managing these microvascular problems of diabetes. Keywords: anaemia, diabetic neuropathy, case control study IJRRMS VOL-3 No.3 JULY - SEP 203 45
Sinha Babu A et al. Anemia and neuropathy in type- 2 diabetes mellitus: A case control study 46 IJRRMS VOL-3 No.3 JULY - SEP 203 IJRRMS 203;3(3)
Neuropathy No neuropathy p-value Age (Years) - 2(4%) 2(4%) 3-45 46-59 20(42%) 8(6%) 8(6%) Male Sex 60 30(60%) 30(60%) BMI 25 36(72%) 0.56 HbAc 7% 36(72%) 28(56%) 0.095 Smoking 2(42%) 26(52%) 0.36 Hypertension 29(58%) 0.409 Total Cholesterol (200 mg/dl) 29 (58%) 22(44%) 0.6 Triglyceride ( 80 mg/dl) 23(46%) 25(50%) 0.688 LDL-C ( 00mg/dl) 34(68%) 0.83 HDL-C ( 40 mg/dl) 8(36%) 2(42%) 0.538 Most of our study population were between 30 to 60 years of age. Sixty six per cent patients had body mass index above 25. Dyslipidemia was common with mean total cholesterol 288 mg/dl, triglyceride 93 mg/dl, LDL cholesterol 27 mg/dl and HDL cholesterol 42 mg/dl. High BMI (>25), smoking, high triglyceride(> 80mg/dl) and low HDL-C ( 40 mg/dl) were more among controls than among cases. On the other hand, poor glycemic control (HbAC 7%), hypertension, high total cholesterol (( 200 mg/dl) and high LDL-C ( 00mg/dl) were more among cases. But none of these differences were statistically significant. The cases and controls are therefore comparable with respect to all these variables. Table 2: Relationship between anemia and neuropathy Neuro No Total pathy neuropathy Anemia 34 2 55 No anemia 6 29 45 50 50 00 P OR/95%CI 0.009 2.93/.2-7.25
Sinha Babu A et al. Anemia and neuropathy in type- 2 diabetes mellitus: A case control study Anemia was more common among cases (68%) than among controls (42%). Table 3: Patterns of neuropathy and their relationship with anemia Anemia No anemia Total Peripheral neuropathy 7 6 5(30%) Autonomic neuropathy 7 2 6(2%) Both 20 8 29(58%) Total 34 6 50 Commonest type of neuropathic presentation was presence of both peripheral and autonomic types. However individual association of any pattern of neuropathy with anemia was found to be not significant. DISCUSSION Anemia is a common accompaniment to diabetes, particularly in patients with albuminuria or reduced renal function. The estimated prevalence of anemia depends on essentially arbitrary criteria used to define the presence or absence of anemia. Using World Health Organisation recommended definition of anemia, nearly one in four patients with diabetes 2 (23%) have anemia warranting evaluation. We found anemia to be common in patients with diabetic patients (55%). However it was more prevalent in presence of neuropathy and the association was statistically significant. Anemia has a negative impact on patient survival, and is considered to be an important cardiovascular risk factor associated with renal disease. Understanding the pathogenesis of anemia associated with diabetes and nephropathy may therefore lead to opportunities for developing interventions to optimize outcomes in these 3 patients. Normocytic normochromic anemia was the most common type in our study supporting the hypothesis of hypoproliferative anemia due to deficiency of erythropoietin to have the most 4 dominating influence. Subjects with normocytic anemia have an increased risk of retinopathy and more often exhibit severe lesions. In a crosssectional survey involving more than 500 diabetic patients, a twofold increased risk of retinopathy was 48 reported in patients with hemoglobin less than 2 5 g/dl. In a study, anemia was found to be a common problem to diabetic patients with albuminuria or 2 reduced renal function. This study demonstrated that anemia is an early and common complication of diabetes and those patients at greatest risk of anemia could be readily identified. Diabetic neuropathy is one of the most common complications of diabetes and may be the first presenting feature. The prevalence of neuropathy has been found to vary widely, 5.4% to 72%, in 6,7 different series, chiefly because of different criteria used to define neuropathy. In our study we have found that concurrent presence of autonomic and peripheral neuropathy was the most common variety of neuropathy. These findings match the 8 findings of Karmakar et al. Another Study showed distal polyneuropathy to be the most common variety of neuropathy and about one third of them were asymptomatic and electrophysiologic evidence of carpal tunnel syndrome correlated 8 significantly with polyneuropathy. In our study, we also found asymptomatic carpal tunnel syndrome to be present in 7 (4%) cases. We did not find any other type of neuropathy. It has been hypothesized that autonomic neuropathy has a complex relationship with anaemia. In one hand anaemia may be due to deficient production of erythropoietin due to autonomic dysfunction. Alternatively anaemia may potentiate autonomic nerve injury by hypoxic 3 insult. We have found that anemia was significantly related to neuropathy. Its association with individual types of neuropathy was not seen, may be because of small number in each category of neuropathy. CONCLUSION Like nephropathy and retinopathy, diabetic neuropathy is also significantly associated with anemia. Evaluation of anemia should be considered in the routine management of persons with diabetes and should be treated to minimize the risk of complications. Addressing anemia in diabetic individuals may have potential to make a great IJRRMS VOL-3 No.3 JULY - SEP 203 IJRRMS 203;3(3)
Sinha Babu A et al. Anemia and neuropathy in type- 2 diabetes mellitus: A case control study impact in managing these microvascular problems of anemia. AUTHOR NOTE Anindita Sinha Babu, Assistant Professor, Pathology, (Corresponding Author); email: anindita.babu@yahoo.com REFERENCES IJRRMS 203;3(3) Abhik Chakrabarti, Assistant Professor, Medicine College of Medicine and Jawaharlal Nehru. G. Deray A. Heurtierb A. Grimaldib V. Launay Vachera C. Isnard Bagnisa. Anemia and Diabetes. Am J Nephrol.2004;24:522 526. 2. Thomas MC, MacIsaac RJ, Tsalamandris C, Power D, Jerums G. Unrecognized anemia in patients with diabetes: a crosssectional survey. Diabetes Care 2003; 26(4): 64-9. 3. Ranil PK, Raman R, Rachepalli SR, Pal SS, Kulothungan V, Lakshmipathy P.etal,. Anemia and diabetic retinopathy in type 2 diabetes mellitus. J Assoc Physicians India. 200 Feb;58:9-4. 4. Savage S, Estacio RO, Jeffers B, Schrier RW. Urinary albumin excretion as a predictor of diabetic retinopathy, nephropathy and cardiovascular disease in NIDDM. Diabetes care. 996;9 (): 243-8. 5. Alvin C. Powers. Diabetes Mellitus. In: Fauci, Braunwald, Kasper, Hauser, Longo, Jameson, Loscalzo editors. Harrison's th Principles of internal Medicine. 7 edition. McGraw-Hill Medical, 2008: 2275-2304. 6. World health organisation- definition, diagnosis and classification of diabetes mellitus: part : diagnosis and classification of diabetes mellitus. Geneva: WHO, 999. 7. World Health Organization. Nutritional anemias: Report of a WHO scientific group. WHO, Geneva. 968 8. Karmakar RN, Khandakar MR, Gangopadhyay PK, Ghosh K, Babu AS. Albuminuria and neuropathy in newly detected diabetics: profile and correlation. J Indian Med Assoc. 20 Jun;09(6):396-9. 9. Veves A, Manes C, Murrey HJ, Young MJ, Boulton AGM. Painful neuropathy and foot ulceration in diabetic patients. Diabetes Care. 993; 6(8): 87-9. 0. Wiles PG, Pearce SM, Rice PJ, Mitchell JM. Vibration perception threshold: influence of age, height, sex and smoking and calculation of accurate centile values. Diabet Med. 99; 8(2): 57-6.. Olaleye D, Perkins BA, Bril V. Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetic clinic. Diabetes Res Clin Pract. 200; 54(2): 5-28. 2. Tentolouris N, Katsilambros N, Papazacos G. Corrected QT interval in relation to the severity of diabetic autonomic neuropathy. Eur J Clin Invest. 997; 27(2): 049-54. 3. Kathrine J. Craig, BSc (Hons), RN. et al. Anemia and diabetes in absence of nephropathy. Diabetes Care. 2005; 28(5):8 23. 4. Winkler AS, Marsden J, Chaudhuri KR, Hambley H, Watkins PJ. Erythropoietin depletion and anemia in diabetes mellitus. Diabet Med. 999;6(0):83 9. 5. Qiao Q, Keinanen F, Kiukanniemi S, Laara E. The relationship between haemoglobin levels and diabetic retinopathy. J Clin Epidemiol.997;50(2):53 8. 6. Tontolouris N, Pagoni S, Tzonou A, Katsilambros N Peripheral neuropathy does not invariably coexist with autonomic neuropathy in diabetes mellitus. Eur J Intern Med. 200; 2(): 20-7. 7. Ashok S, Ramu M, Deepa R, Mohan V. Prevalence of neuropathy in type 2 diabetes attending a diabetes centre in South India. J Assoc Physicians India. 2002; 50:546-50. 8. Dyck PJ, Kratz KM, Karnes JL et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy and nephropathy in a population based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 993; 43: 87-24. IJRRMS VOL-3 No.3 JULY - SEP 203 49